# Emergency Use of an Investigational Drug or Biologic:  Guidance for Institutional Review Boards and Clinical Investigators - FDA Guidance Document

Source: https://www.keypedia.com/guidances/information-sheet/emergency-use-of-an-investigational-drug-or-biologic-guidance-for-institutional-review-boards-and-clinical-investigators/5124752e-b681-4485-8d11-7368abfec2c6

> FDA guidance document: Emergency Use of an Investigational Drug or Biologic:  Guidance for Institutional Review Boards and Clinical Investigators. Issue date: January 01, 1998. Get complete insights and analysis.

---

## Details

- Title: Emergency Use of an Investigational Drug or Biologic:  Guidance for Institutional Review Boards and Clinical Investigators
- Communication Type: Information Sheet
- Product Type: Biologics, Drugs
- Office Name: Office of the Commissioner,Office of Clinical Policy and Programs,Office of Clinical Policy,Office of Good Clinical Practice
- Issue Date: 1998-01-01

## Related Documents

- [Recruiting Study Subjects:  Guidance for Institutional Review Boards and Clinical Investigators](https://www.keypedia.com/guidances/information-sheet/recruiting-study-subjects-guidance-for-institutional-review-boards-and-clinical-investigators/9a90f31a-c6dd-4dd4-bb32-8e81a4eafd57)
- [Cooperative Research:  Guidance for Institutional Review Boards and Clinical Investigators](https://www.keypedia.com/guidances/information-sheet/cooperative-research-guidance-for-institutional-review-boards-and-clinical-investigators/0aab2c7a-11f8-4aee-8aa1-0936f4cb08be)
- [Use of Investigational Products When Subjects Enter a Second Institution:  Guidance for Institutional Review Boards and Clinical Investigators](https://www.keypedia.com/guidances/information-sheet/use-of-investigational-products-when-subjects-enter-a-second-institution-guidance-for-institutional-review-boards-and-clinical-investigators/e2034c31-e0cf-45da-af64-82293c9af76c)